Phase 2 Trial to Evaluate Safety of Subcutaneous Epcoritamab Monotherapy in the Outpatient Setting Among Patients with Relapsed or Refractory Diffuse Grade 1-3a Large B-Cell and Follicular Lymphoma (EPCORE NHL-6)

被引：3

作者：

Sharman, Jeff P. ^{[1
]}

Boccia, Ralph, V ^{[2
]}

Doerr, Thomas ^{[3
]}

Conte, Kristin ^{[3
]}

Bai, Yang ^{[3
]}

Elliott, Brian ^{[4
]}

Andorsky, David J. ^{[5
]}

机构：

[1] Willamette Valley Canc Inst, Eugene, OR USA

[2] Ctr Canc & Blood Disorders, Bethesda, MD USA

[3] AbbVie Inc, N Chicago, IL USA

[4] Genmab, Princeton, NJ USA

[5] Rocky Mt Canc Ctr, Boulder, CO USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-157575

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9491 / 9492

页数：2

共 50 条

[1] Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6
Andorsky, David Jacob
Boccia, Ralph V.
Lash, Bradley Walter
Vaidya, Rakhee
Gandhi, Mitul
Patel, Ameet
Ibrahimi, Sami
Madueno, Fernando Manuel Vargas
Lee, Christina Y.
Naik, Seema
Haydu, J. Erika
Fesler, Mark
Osei-Bonsu, Kojo
Conte, Kristin
Doerr, Thomas
Bai, Yang
Sacchi, Mariana
Sharman, Jeff Porter
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[2] Subcutaneous epcoritamab in Japanese patients with relapsed/refractory diffuse large B-cell lymphoma: EPCORE NHL-3 data
Izutsu, Koji
Kumode, Takahiro
Yuda, Junichiro
Nagai, Hirokazu
Mishima, Yuko
Suehiro, Youko
Yamamoto, Kazuhito
Fujisaki, Tomoaki
Ishitsuka, Kenji
Ishizawa, Kenichi
Ikezoe, Takayuki
Nishikori, Momoko
Akahane, Daigo
Fujita, Jiro
Wu, Jun
Broberg, Per
Buchbjerg, Jeppe
Fukuhara, Noriko
ANNALS OF ONCOLOGY, 2023, 34 : S1389 - S1389
[3] Subcutaneous Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: Pivotal Results from the Phase 2 EPCORE NHL-1 Trial
Catherine, Thieblemont
Tycel, Phillips
Herve, Ghesquieres
Cheah, Chan Y.
David, Cunningham
Do, Young R.
Tatyana, Feldman
Robin, Gasiorowski Robin
Wojciech, Jurczak
Tae, Min Kim Tae M.
Lewis, David J.
Mariolein, Van der Poe
Poon, Michelle L.
Thomas, Doerr
Nurgul, Kilavuz
Menghui, Chen
Mariana, Sacchi
Martin, Hutchings
Pieternella, Lugtenburg
Roost, Clausen Michael
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S31 - S32
[4] Subcutaneous Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma from EPCORE NHL-5
Mazza, Irit Avivi
Kim, Won Seog
Ko, Shen
Grande, Carlos
Lavie, David
Chism, David
Seliem, Mostafa
Jeng, Edwin E.
Joshi, Neha
Siddani, Satya
Assaily, Wissam
Sacchi, Mariana
Dinh, Minh
Avigdor, Abraham
BLOOD, 2023, 142
[5] Subcutaneous Epcoritamab Versus Standard of Care in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase 3 EPCORE DLBCL-1 Trial
Fox, Christopher P.
Roost, Clausen Michael
Pieternella, Lugtenburg
Balari, Anna S.
Zinzani, Pier L.
Jun, Wu
Laura, Finn
Vindelov, Signe D.
Catherine, Thieblemont
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S32 - S33
[6] Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
Thieblemont, Catherine
Phillips, Tycel
Ghesquieres, Herve
Cheah, Chan Y.
Clausen, Michael Roost
Cunningham, David
Do, Young Rok
Feldman, Tatyana
Gasiorowski, Robin
Jurczak, Wojciech
Kim, Tae Min
Lewis, David John
van der Poel, Marjolein
Poon, Michelle Limei
Doerr, Thomas
Kilavuz, Nurgul
Chen, Menghui
Sacchi, Mariana
Elliott, Brian
Hutchings, Martin
Lugtenburg, Pieternella
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S379 - S379
[7] Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma
Izutsu, Koji
Kumode, Takahiro
Yuda, Junichiro
Nagai, Hirokazu
Mishima, Yuko
Suehiro, Youko
Yamamoto, Kazuhito
Fujisaki, Tomoaki
Ishitsuka, Kenji
Ishizawa, Kenichi
Ikezoe, Takayuki
Nishikori, Momoko
Akahane, Daigo
Fujita, Jiro
Dinh, Minh
Soong, David
Noguchi, Hidehisa
Buchbjerg, Jeppe Klint
Favaro, Elena
Fukuhara, Noriko
CANCER SCIENCE, 2023, 114 (12) : 4643 - 4653
[8] Subcutaneous Epcoritamab in Patients with Relapsed/ Refractory Large B-Cell Lymphoma: Longer-Term Results From the Pivotal EPCORE NHL-1 Trial
Tatyana, Feldman
Yasmin, Karimi
Herve, Ghesquieres
Wojciech, Jurczak
Chan, Cheah Y.
Michael, Roost Clausen
Pieternella, Lugtenburg
David, Cunningham
Do Young, Rok
John, Lewis David
Robin, Gasiorowski
Min, Kim Tae
Marjolein, van der Poel
Michelle, Limei Poon
Kim, Linton M.
Anna, Sureda
Martin, Hutchings
Mariana, Cota Stirner
Mariana, Sacchi
Catherine, Thieblemont
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S49 - S50
[9] Epcoritamab in Japanese patients with relapsed/refractory diffuse large B-cell lymphoma: EPCORE NHL-3 longer-term data
Izutsu, K.
Kumode, T.
Yuda, J.
Nagai, H.
Mishima, Y.
Suehiro, Y.
Yamamoto, K.
Fujisaki, T.
Ishitsuka, K.
Ishizawa, K.
Ikezoe, T.
Nishikori, M.
Akahane, D.
Fujita, J.
Jafarinasabian, P.
Noguchi, H.
Buchbjerg, J.
Favaro, E.
Fukuhara, N.
ANNALS OF ONCOLOGY, 2024, 35 : S1324 - S1325
[10] Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Linton, Kim M.
Vitolo, Umberto
Jurczak, Wojciech
Lugtenburg, Pieternella J.
Gyan, Emmanuel
Sureda, Anna
Christensen, Jacob Haaber
Hess, Brian
Tilly, Herve
Cordoba, Raul
Lewis, David John
Okada, Craig
Hutchings, Martin
Clausen, Michael Roost
Sancho, Juan-Manuel
Cochrane, Tara
Leppa, Sirpa
Chamuleau, Martine E. D.
Gernhardt, Diana
Altintas, Isil
Liu, Yan
Ahmadi, Tahamtan
Dinh, Minh H.
Hoehn, Daniela
Favaro, Elena
Elliott, Brian
Thieblemont, Catherine
Vose, Julie M.
LANCET HAEMATOLOGY, 2024, 11 (08): : e593 - e605

← 1 2 3 4 5 →